Condition: Urinary Bladder Cancer

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT05822934

Sponsor: Assiut University

Phase: Phase 3

Eligibility:

• Age: minimum 18 Years maximum N/A
• Gender: All

Inclusion Criteria:

• All patients diagnosed with muscle invasive urinary bladder cancer that can receive chemotherapy are included the criteria are
• • Age above 18 years,
• Pathologically proven urinary bladder cancer,
• Patients with clinical stages T2-4a N0-3 M0,
• Patients with good renal and liver functions
• patients with no distant metastases,
• no other malignancy (double malignancy).
• Performance status 0-1 according to ECOG performance status scale.
• Patients with no contraindications for radiotherapy.

Exclusion Criteria:

• • performance status 2-4 according to ECOG performance status scale.
• patients refuse to receive chemotherapy,
• patients not eligible to receive chemotherapy due to liver or renal impairment or thrombocytopenia,
• patients with M1 disease.

View trial on ClinicalTrials.gov